A fairly new birth control pill has the FDA looking into its safety. While the federal oversight agency did approve Yaz, a popular new pill created by Bayer, they are now worried the medication leads to blood clots.
The study
According to a report by MSNBC, “A new study released by the Food and Drug Administration reviewed the medical history of more than 800,000 U.S. women taking different forms of birth control between 2001 and 2007. On average, women taking Yaz had a 75 percent greater chance of experiencing a blood clot than women taking older birth control drugs.”
This particular birth control has a new ingredient, drospirenone, which researchers believe is causing the unsafe spike in the blood clots.
Not the only pill containing new ingredient
Birth-control pills that contain drospirenone include Bayer’s Yaz, Yasmin, Beyaz, Safyral; Sandoz’s Syeda and Loryna; as well as Barr Laboratories’ Ocella, Watson Pharmaceuticals’ Zarah and Teva Pharmaceuticals’ Loryna.
Not the first inquiry
Several months ago the FDA forced Bayer to run corrective ads about Yaz. They had claimed the pill helped clear acne and battle severe premenstrual cramps. The FDA felt the maker’s overstated the pill’s effectiveness and forced new commercials. Now, scientists are testing the pills safety.
Reaction from medical community
Some doctors are disturbed that Yaz was even approved by the FDA in the first place. “At a certain point we have to ask why the FDA continues to approve drugs that are less safe and have no benefit compared to drugs already on the market,” said Dr. Diana Zuckerman, president of the National Center for Women and Families, a consumer group for women’s health issues. “With all these different birth control options, why take the most expensive one that can also kill you?”
The FDA is holding a meeting in early December to make a decision about the pill.
We specialize in providing our over 1,000,000 customers with relevant product and condition information created by our professional editorial staff which includes our team of medical writers, medical practitioners, and health educators. eDrugStore.com Staff on Facebook